ClinicalTrials.Veeva

Menu

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

N

Ningbo No. 1 Hospital

Status

Completed

Conditions

Nonalcoholic Fatty Liver Disease
Type2 Diabetes Mellitus
Light-to-moderate Alcohol Consumption

Study type

Observational

Funder types

Other

Identifiers

NCT03847116
LHNAFLD 2018-V1.0

Details and patient eligibility

About

This study explored the cross-sectional and prospective associations between light-to-moderate alcohol consumption (LMAC) and risk of type 2 diabetes mellitus (T2DM) in individuals with nonalcoholic fatty liver disease (NAFLD).

Enrollment

14,014 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. aged 18 years or above
  2. undergoing annual health examinations in 2009 in Zhenhai Lianhua Hospital, Ningbo, China.
  3. informed about the study

Exclusion criteria

  1. female participants;
  2. missing data on ultrasound, alcohol consumption, and T2DM status;
  3. alcohol consumption > 210 g per week, and binge drinkers;
  4. with evidence of other liver diseases including viral hepatitis, autoimmune hepatitis, and drug-induced liver disease.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems